Sanofi-Aventis To Launch Generic Allegra To Battle Risky Patent Challenge

By Marius Meland (September 13, 2005, 12:00 AM EDT) -- Drug maker Sanofi-Aventis SA will launch an authorized generic version of the allergy pill Allegra in the U.S. to fight off competition from rival drug makers, which shocked analysts earlier this month with an unusually bold generic launch in the midst of a patent challenge for the $1.4 billion drug....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!